Cart
sales@molnova.com
HA-155
CAS No. 1229652-22-5
HA-155 ( Autotaxin Inhibitor IV )
Catalog No. M23406 CAS No. 1229652-22-5
HA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 56 | In Stock |
|
| 5MG | 119 | In Stock |
|
| 10MG | 213 | In Stock |
|
| 25MG | 511 | In Stock |
|
| 50MG | 644 | In Stock |
|
| 100MG | 786 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHA-155
-
NoteResearch use only, not for human use.
-
Brief DescriptionHA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
-
DescriptionHA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
-
SynonymsAutotaxin Inhibitor IV
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorATX (autotaxin)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1229652-22-5
-
Formula Weight463.3
-
Molecular FormulaC24H19BFNO5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESB(C1=CC=C(C=C1)COC2=CC=C(C=C2)/C=C\3/C(=O)N(C(=O)S3)CC4=CC=C(C=C4)F)(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Albers H M H G , Hendrickx L J D , Van Tol R J P , et al. Structure-Based Design of Novel Boronic Acid-Based Inhibitors of Autotaxin[J]. Journal of Medicinal Chemistry, 2011, 54(13):4619-26.
molnova catalog
related products
-
Nortadalafil
Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
-
Ro 20-1724
Ro20-1724 is a widely used inhibitor of cyclic nucleotide phosphodiesterase with IC50 of 2.0 μM and Ki of 3.1 μM.
-
GSK-256066
A potent, selective PDE4 inhibitor with pIC50 of 11.5, 11.3, 11.4, and 11.9 for PDE4B, A, C, and D, respectively.
